Dapa-HF

Evaluation of the effect of dapagilifiozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction.

Type: Drug trial

Principal Investigator: John B. Kostis, MD

Trial is open for enrollment

• Rutgers Robert Wood Johnson Medical School
• Robert Wood Johnson University Hospital